Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


Symfo launches new language for eDiary product


Boston, MA — September 25, 2006 — Symfo, a leading provider of electronic patient reported outcome (ePRO) solutions for clinical trials, announced today that its SymQuest eDiary is now available in the Hebrew language.

“With so many clinical trials taking place today on a global level, it is important to offer customers additional language support,” said Serge Bodart, Chief Executive Officer of Symfo. “By now being able to offer the Hebrew language on top of our 17 other languages on our SymQuest product, we are giving our clients the possibility to utilize more and more sites and patients worldwide. Couple this with our guaranteed data transmission technology, and the possibilities are pretty exciting indeed.”

The SymQuest is Symfo’s Palm-based electronic patient diary, and is an ideal tool for capturing Quality of Life assessments and daily diary recording for patients in real time.

The SymQuest was recently deployed in a large, multinational, multilingual clinical trial taking place in 12 different countries around the globe. Thanks to Symfo’s easy-to-use patient diary and reliable IDR system for sending data, their client is on track for a faster database lock time than previously achieved with other vendors.

Symfo is currently working on different projects in Eastern Europe and Asia that will add even more language capability.


ABOUT SYMFO
Symfo is an international organization specializing in electronic patient diary solutions, including the SymPro electronic patient diary, the SymQuest Palm-based diary and the SymVoice IVR. They are all simple to use and affordable solutions enabling study participants to easily implement electronic patient diaries in all phases of clinical trials and post-marketing studies.

Symfo’s FDA-compliant handheld devices (SymPro & SymQuest) utilize Symfo’s unique IDR system (Interactive Diary Response) – providing all the advantages of a handheld device (easy to carry, fits in your pocket) combined with simple, reliable phone-based data transfer. Symfo’s IDR system guarantees 100% successful transmission of patient data – and works anywhere in the world.

To find out more about how Symfo’s technology can improve your clinical trials, please visit www.symfo.com.


Publisher Contact Information:

SYMFO
617-577-9484
erik.falvey@symfo.com

Past press releases of SYMFO.

Data


25,099
Tech investments
From our Online Data Service
16,240
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Dec 7€6.3MNanotechnology
Dec 7€21.1MInternet commerce
Dec 7€4.8MInternet commerce
Dec 7€1.8MInternet commerce
Dec 6N/AInternet commerce
Dec 6€26.0MBusiness applications
Dec 6€5.6MMedical devices

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...

Aug 17
Komed Health
komed health closes seed financing round

Jul 10
Komed Health
komed health to be supported by nokia and deutsche telekom





About usContact usLegal Information
Copyright © 1999-2018
Emerging Technology Research Europe Inc. All rights reserved.